AndreaBozzo/ceres-open-data-index huggingface dataset:
Death Summary by Age, New York State: Beginning 2018

This dataset contains the number of New York State deaths by age group and jurisdiction stratified by sex, race, ethnicity, cause of death, type of institution, type of disposition and veteran status. The data presented here may differ from the Vital Statistics tables on the Department public website due to data updates. For more information, visit  https://www.health.ny.gov/statistics/vital_statistics/vs_reports_tables_list.htm, where information from this dataset is presented in tabular form in Table 32.
Compound 529326: Oxetane, 3-methyl-3-(2-methyl-1-[3-methylphenyloxy)propyl]

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-3-[2-methyl-1-(3-methylphenoxy)propyl]oxetane. Molecular Formula: C15H22O2. Molecular Weight: 234.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528243: 2-Butyl-3,5-dimethylthiophene

Chemical compound data from PubChem database. IUPAC Name: 2-butyl-3,5-dimethylthiophene. Molecular Formula: C10H16S. Molecular Weight: 168.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Annotated Bibliography Informing Training and Technical Assistance

To support the Permanency Innovations Initiative (PII) Grantees in better meeting the needs of children and families, the PII Training and Technical Assistance Project (PII-TTAP) team created the Annotated Bibliography Informing Training and Technical Assistance. PII-TTAP conducted extensive research to develop and refine the Development, Implementation, and Assessment Approach and organized the research into an annotated bibliography related to organizational and system development, change management, leadership, and implementation science.

Metadata-only record linking to the original dataset. Open original dataset below.
National Survey of Residential Care Facilities - Restricted Resident-Level Dataset

The 2010 National Survey of Residential Care Facilities (NSRCF) is a first-ever national probability sample survey that collects data on U.S. residential care providers, their staffs and services, and the people they serve. It is designed to provide national estimates of the number of residential care facilities operating in the United States, the number of residents receiving care, and the characteristics of both the facilities and their residents. NSRCF was conducted between March and November 2010. All residential care facilities that participated in the survey were places that were licensed, registered, listed, certified, or otherwise regulated by the state and that had 4 or more licensed, certified, or registered beds, provided room and board with at least two meals a day, around-the-clock on-site supervision, and help with personal care such as bathing and dressing or health related services such as medication management. These facilities served a predominantly adult population and had at least one current resident. Facilities licensed to serve the mentally ill or the developmentally disabled populations exclusively were excluded from the survey.
Compound 527056: 2,6,6-Trimethyl-1-(but-2-enoyl)-cyclohex-2-en-4-one

Chemical compound data from PubChem database. IUPAC Name: 4-but-2-enoyl-3,5,5-trimethylcyclohex-2-en-1-one. Molecular Formula: C13H18O2. Molecular Weight: 206.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Is there a role for glucocorticoid receptor beta in asthma?

Glucocorticoids (GCs) are routinely used as anti-inflammatory drugs in the treatment of asthma. They act through binding to glucocorticoid receptor α (GRα), which represses numerous genes encoding pro-inflammatory mediators. A hormone binding deficient GR isoform named GRβ has been isolated in humans. When overexpressed by transfection, GRβ may function as a dominant negative modulator of GRα. However, to act as such, GRβ has to be more abundant than GRα, and conflicting data have been obtained concerning the relative levels of the two isoforms in cell lines and freshly isolated cells. Moreover, the dominant negative effect was not confirmed by independent laboratories. In GC-resistant asthmatics, GRβ was expressed by an increased number of peripheral blood mononuclear cells (PBMCs), airway T cells, and cells found in skin biopsies of tuberculin responses. However, the relative amounts of GRα and GRβ in these cells were not determined. In GC-dependent asthmatics, PBMCs expressed GRα predominantly. No cells containing higher levels of GRβ than GRα have yet been reported in asthmatics. Even if the existence of such cells is demonstrated, the role of GRβ in asthma will remain a matter of controversy because functional studies have given discrepant data.
Miscellaneous Tables (Prevalence Estimates) - 6.1 to 6.107

These detailed tables present totals and prevalence estimates of the number of days and types of substance use, poly-drug use, nicotine dependence, substance dependence by age of first use, source of substances, social context of substance use, and drunk/drugged driving from the 2010 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Results are provided for lifetime, past year, and past month use by age group, gender, race/ethnicity, education level, employment status, geographic area, pregnancy status, college enrollment status, and probation/parole status. Comparisons are made between 2010 and 2009.
Compound 529821: Pentanal, 2,4,6-trichlorophenyl hydrazone, #1

Chemical compound data from PubChem database. IUPAC Name: 2,4,6-trichloro-N-(pentylideneamino)aniline. Molecular Formula: C11H13Cl3N2. Molecular Weight: 279.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Substance Use and Substance Use Disorder by Industry

This National Survey on Drug Use and Health (NSDUH) short report looks at trends in illicit drug use, heavy alcohol use, substance use disorder (SUD) among persons aged 18 to 64 who are employed full time. The report includes compares rates of substance use and SUD across the industry in which employees work.  It also includes comparisons of estimates within each industy from the combined 2008 to 2012 NSDUHs with the combined 2003 to 2007 NSDUHs. The industries examined include: Accommodations and food services; Construction; Arts, entertainment, and recreation; Information; Management; Retail trade; Wholesale trade; Professional, scientific, and technical services; Real estate; Mining; Finance and insurance; Manufacturing; Transportation and warehousing; Agriculture, forestry, fishing, and hunting; Health care and social assistance; Public administration; Educational services; and Utilities.
Compound 528189: 1,10-Diiodoperfluorodecane

Chemical compound data from PubChem database. IUPAC Name: 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10-icosafluoro-1,10-diiododecane. Molecular Formula: C10F20I2. Molecular Weight: 753.88. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399667-T1: [Translated] DEVICE FOR BLOCKING THE OPENING OF A SLIDING SIDE DOOR OF A VEHICLE AND VEHICLE COMPRISING THIS DEVICE

The device has a hook (23) displaced between a hooking position of a sliding side door (9) and a releasing position of the door. A cable (29) drives the hook by controlling the movement of a flap (19) of a fuel tank and has a piston (41) and a ramp (39) that is integrated to the flap. The piston and the ramp cooperate to drive the hook in the hooking position, when the flap is in an opening position, and in the releasing position when the flap is in a closing position. The ramp is integrated to a knuckle (32) of the flap and spaced from a valve (31) of the flap.
2011 CMHS Uniform Reporting System (URS) Output Tables for California

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Construction and high cytoplasmic expression of a tumoricidal single-chain antibody against hepatocellular carcinoma

Background
          Hep27 monoclonal (Hep27 Mab) is an antibody against hepatocellular carcinoma. Hep27 Mab itself can inhibit the growth of a hepatocellular carcinoma cell line (HCC-S102). We attempted to produce a single-chain fragment (scFv), a small fragment containing an antigen-binding site of Hep27 Mab, by using DNA-recombinant techniques.
        
        
          Results
          The sequences encoding the variable regions of heavy (VH) and light (VL) chains of a murine Hep27 Mab were linked together by a linker peptide (Gly4Ser)3 and tagged with a hexa-histidine at the C-terminal; the resultant DNA construct was expressed in E. coli as an insoluble protein. The denatured scFv was refolded and purified by immobilized metal ion affinity chromatography (12 mg/l with a molecular weight of 27 kDa). Hep27scFv exhibited a tumoricidal activity against the HCC-S102 cell as its parental antibody (Hep27 Mab).
        
        
          Conclusion
          This scFv may be a potential candidate for a targeting agent in HCC immunodiagnosis or immunotherapy.
Compound 526387: 1,7-Dibromo,2,3-dichloro-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1,7-dibromo-2,3-dichlorodibenzo-p-dioxin. Molecular Formula: C12H4Br2Cl2O2. Molecular Weight: 410.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529617: Bis(trimethylsilyl) 2-[(trimethylsilyl)amino]succinate

Chemical compound data from PubChem database. IUPAC Name: bis(trimethylsilyl) 2-(trimethylsilylamino)butanedioate. Molecular Formula: C13H31NO4Si3. Molecular Weight: 349.64. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401546-T1: [Translated] METHOD FOR DETERMINING A FIRE CONTROL SOLUTION

A method of determining a firing guidance solution when relative movement exists between a projectile-firing weapon and a target object that is to be hit, including the steps of adjusting the weapon in azimuth angle and elevation angle, by means of a movement differential equation solution method determining a projectile point of impact and flight times at prescribed azimuth and elevation angle values in view of the ammunition used and external influences, varying the azimuth and elevation angles, as input parameters of the movement differential equation solution method, until a firing guidance solution is found, taking into consideration the weapon and target object speeds, providing a function J (α, ε) that assumes a particular value J* when the azimuth and elevation angles represent a firing guidance solution, and selectively iteratively varying the azimuth and elevation angles using mathematical processes such that the particular value J* is found.
CMS Program Statistics - Medicare Outpatient Facility

The CMS Program Statistics - Medicare Outpatient Facility tables provide use and payment data for all outpatient facilities, including hospitals providing outpatient services, rural health clinics, community mental health centers, federally qualified health centers, outpatient dialysis facilities, comprehensive outpatient rehabilitation facilities, and other outpatient facilities. 

For additional information on enrollment, providers, and Medicare use and payment, visit the CMS Program Statistics page.

 

Below is the list of tables:


	MDCR OUTPATIENT 1.  Medicare Outpatient Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Entitlement, Yearly Trend
	MDCR OUTPATIENT 2.  Medicare Outpatient Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Demographic Characteristics and Medicare-Medicaid Enrollment Status
	MDCR OUTPATIENT 3.  Medicare Outpatient Facilities:  Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Area of Residence
	MDCR OUTPATIENT 4.  Medicare Outpatient Facilities:  Utilization and Program Payments for Original Medicare Beneficiaries, by Type of Outpatient Facility
	MDCR OUTPATIENT 5.  Medicare Outpatient Facilities:  Utilization for Original Medicare Beneficiaries, by Type of Outpatient Facility and Type of Service
	MDCR OUTPATIENT 6.  Medicare Outpatient Prospective Payment System Hospitals: Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Entitlement, Yearly Trend
	MDCR OUTPATIENT 7.  Medicare Outpatient Prospective Payment System Hospitals: Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Demographic Characteristics and Medicare-Medicaid Enrollment Status
	MDCR OUTPATIENT 8.  Medicare Outpatient Prospective Payment System Hospitals: Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Area of Residence
	MDCR OUTPATIENT 9.  Medicare Outpatient Critical Access Hospitals: Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Type of Entitlement, Yearly Trend
	MDCR OUTPATIENT 10.  Medicare Outpatient Critical Access Hospitals: Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Demographic Characteristics and Medicare-Medicaid Enrollment Status
	MDCR OUTPATIENT 11.  Medicare Outpatient Critical Access Hospitals: Utilization, Program Payments, and Cost Sharing for Original Medicare Beneficiaries, by Area of Residence
Compound 528843: Glycerol, 2,3-dimethyl, 1-hexadecanoate

Chemical compound data from PubChem database. IUPAC Name: 2,3-dimethoxypropyl hexadecanoate. Molecular Formula: C21H42O4. Molecular Weight: 358.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital

NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 528738: p-Octopamine, DTFMB-TMS

Chemical compound data from PubChem database. IUPAC Name: 3,5-bis(trifluoromethyl)-N-[2-trimethylsilyloxy-2-(4-trimethylsilyloxyphenyl)ethyl]benzamide. Molecular Formula: C23H29F6NO3Si2. Molecular Weight: 537.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
COVID-19  Hospital Data Coverage

The Secretary's Guidance for Hospital Reporting and FAQ and the new CMS Interim Final Rule with Comment Period (IFC) require all hospitals who are licensed to provide 24 hour care to report all of the mandatory non-supply fields seven days a week within 1 business day of the reporting date (except for psychiatric and rehabilitation facilities who must report weekly). This includes short term, long term, critical access, childrens, Medicaid only short term, Medicaid only childrens,  Distinct Part Psychiatric Hospital, and Medicaid only long term hospitals and refers to items 1 - 24 in the Guidance for Hospital Reporting and FAQ. Hospitals are only required to report supply related fields (items 26, 27, 29, 30, 31) on Wednesdays.
Behavioral Health Barometer: South Dakota, 2014

This is a behavioral health report for the state of South Dakota. It uses the  National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment Services (NSSATS) to address the topics of youth substance use , youth mental health and treatment, adult mental health and treatment, substance use, substance use treatment, and medicare enrollees for the years 2009 to 2013.
Cell density related gene expression: SV40 large T antigen levels in immortalized astrocyte lines

Background
          Gene expression is affected by population density. Cell density is a potent negative regulator of cell cycle time during exponential growth. Here, we asked whether SV40 large T antigen (Tag) levels, driven by two different promoters, changed in a predictable and regular manner during exponential growth in clonal astrocyte cell lines, immortalized and dependent on Tag.
        
        
          Results
          Expression and cell cycle phase fractions were measured and correlated using flow cytometry. T antigen levels did not change or increased during exponential growth as a function of the G1 fraction and increasing cell density when Tag was transcribed from the Moloney Murine Leukemia virus (MoMuLV) long terminal repeat (LTR). When an Rb-binding mutant T antigen transcribed from the LTR was tested, levels decreased. When transcribed from the herpes thymidine kinase promoter, Tag levels decreased. The directions of change and the rates of change in Tag expression were unrelated to the average T antigen levels (i.e., the expression potential).
        
        
          Conclusions
          These data show that Tag expression potential in these lines varies depending on the vector and clonal variation, but that the observed level depends on cell density and cell cycle transit time. The hypothetical terms, expression at zero cell density and expression at minimum G1 phase fraction, were introduced to simplify measures of expression potential.
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

The diagnosis of rheumatoid arthritis (RA) is primarily based on clinical symptoms, so it is often difficult to diagnose RA in very early stages of the disease. A disease-specific autoantibody that could be used as a serological marker would therefore be very useful. Most autoimmune diseases are characterized by a polyclonal B-cell response targeting multiple autoantigens. These immune responses are often not specific for a single disease. In this review, the most important autoantibody/autoantigen systems associated with RA are described and their utility as a diagnostic and prognostic tool, including their specificity, sensitivity and practical application, is discussed. We conclude that, at present, the antibody response directed to citrullinated antigens has the most valuable diagnostic and prognostic potential for RA.
Patent AT-E399838-T1: [Translated] PHOSPHATE FLUORTENSIDE FOR USE IN CARBON DIOXIDE

A method of removing water from a composition of matter comprises contacting a first composition of matter comprising water with a second composition of matter comprising: (1) at least one surfactant comprising at least one phosphate group and (2) a solvent comprising carbon dioxide, wherein at least a portion of the surfactant is soluble in the solvent, such that the at least one surfactant removes at least a portion of the water from the first composition.
Compound 530028: Benzaldehyde, 3-methoxy-4-[(trimethylsilyl)oxy]-, O-methyloxime

Chemical compound data from PubChem database. IUPAC Name: N-methoxy-1-(3-methoxy-4-trimethylsilyloxyphenyl)methanimine. Molecular Formula: C12H19NO3Si. Molecular Weight: 253.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.